Suman Srinivasa1, Kathleen V Fitch1, Martin Torriani2, Markella V Zanni1, Christopher Defilippi3, Robert Christenson4, Patrick Maehler1, Sara E Looby1,5, Janet Lo1, Steven K Grinspoon1. 1. Program in Nutritional Metabolism. 2. Division of Musculoskeletal Imaging and Intervention, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. 3. Cardiology Division, Inova Health System, Falls Church, Virginia. 4. Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland. 5. Yvonne L. Munn Center for Nursing Research, Massachusetts General Hospital, Boston, Massachusetts, USA.
Abstract
OBJECTIVE: Persons living with HIV (PLWH) well treated on antiretroviral therapies remain at risk for ensuing arterial disease. We investigated the relationship between adipose depots and biomarkers of arterial injury and inflammation to gain insight into the link between body composition and CVD risk. DESIGNS/ METHODS: One hundred and fifty-five HIV-infected and 70 non-HIV infected individuals were well phenotyped for body composition. Adipose depots were assessed via single-slice abdominal computed tomography (CT). Circulating markers of arterial disease and generalized inflammation [lipoprotein-associated phospholipase A2 (LpPLA2), oxidized low-density lipoprotein (oxLDL), high-sensitivity cardiac troponin T (hs-cTnT), high-sensitivity C-reactive protein (hsCRP)] were evaluated. RESULTS: Despite similar BMI and visceral adipose tissue (VAT), HIV-infected individuals had significantly lower subcutaneous adipose tissue [SAT, 199 (126-288) vs. 239 (148-358) cm(2), P = 0.04] than non-HIV infected individuals. Among HIV-infected individuals, reduced SAT inversely correlated with LpPLA2 (ρ = -0.19, P = 0.02) and hs-cTnT (ρ = -0.24, P = 0.004), whereas increased VAT significantly and positively related to LpPLA2 (ρ = 0.25, P = 0.003), oxLDL (ρ = 0.28, P = 0.0005), hs-cTnT (ρ = 0.28, P = 0.0007) and hsCRP (ρ = 0.32, P = < 0.0001). Similar analyses among the non-HIV infected individuals revealed significant relationships between SAT and LpPLA2 (ρ = -0.24, P = 0.05), as well as VAT and LpPLA2 (ρ = 0.37, P = 0.002), oxLDL (ρ = 0.24, P = 0.05) and hsCRP (ρ = 0.29, P = .02). In modelling performed among the HIV group, simultaneously controlling for VAT, SAT, age and relevant HIV-related parameters, reduced SAT was an independent predictor of LpPLA2 (P = 0.04) and hs-cTnT (P = 0.005) and increased VAT was an independent predictor of LpPLA2 (P = 0.001), oxLDL (P = 0.02), hs-cTnT (P = 0.04) and hsCRP (P = 0.04). CONCLUSION: Fat redistribution phenotypes, characterized by SAT loss and/or VAT accumulation, may be linked to arterial injury and inflammation in HIV.
OBJECTIVE:Persons living with HIV (PLWH) well treated on antiretroviral therapies remain at risk for ensuing arterial disease. We investigated the relationship between adipose depots and biomarkers of arterial injury and inflammation to gain insight into the link between body composition and CVD risk. DESIGNS/ METHODS: One hundred and fifty-five HIV-infected and 70 non-HIV infected individuals were well phenotyped for body composition. Adipose depots were assessed via single-slice abdominal computed tomography (CT). Circulating markers of arterial disease and generalized inflammation [lipoprotein-associated phospholipase A2 (LpPLA2), oxidized low-density lipoprotein (oxLDL), high-sensitivity cardiac troponin T (hs-cTnT), high-sensitivity C-reactive protein (hsCRP)] were evaluated. RESULTS: Despite similar BMI and visceral adipose tissue (VAT), HIV-infected individuals had significantly lower subcutaneous adipose tissue [SAT, 199 (126-288) vs. 239 (148-358) cm(2), P = 0.04] than non-HIV infected individuals. Among HIV-infected individuals, reduced SAT inversely correlated with LpPLA2 (ρ = -0.19, P = 0.02) and hs-cTnT (ρ = -0.24, P = 0.004), whereas increased VAT significantly and positively related to LpPLA2 (ρ = 0.25, P = 0.003), oxLDL (ρ = 0.28, P = 0.0005), hs-cTnT (ρ = 0.28, P = 0.0007) and hsCRP (ρ = 0.32, P = < 0.0001). Similar analyses among the non-HIV infected individuals revealed significant relationships between SAT and LpPLA2 (ρ = -0.24, P = 0.05), as well as VAT and LpPLA2 (ρ = 0.37, P = 0.002), oxLDL (ρ = 0.24, P = 0.05) and hsCRP (ρ = 0.29, P = .02). In modelling performed among the HIV group, simultaneously controlling for VAT, SAT, age and relevant HIV-related parameters, reduced SAT was an independent predictor of LpPLA2 (P = 0.04) and hs-cTnT (P = 0.005) and increased VAT was an independent predictor of LpPLA2 (P = 0.001), oxLDL (P = 0.02), hs-cTnT (P = 0.04) and hsCRP (P = 0.04). CONCLUSION: Fat redistribution phenotypes, characterized by SAT loss and/or VAT accumulation, may be linked to arterial injury and inflammation in HIV.
Authors: Markella V Zanni; Mabel Toribio; Gregory K Robbins; Tricia H Burdo; Michael T Lu; Amorina E Ishai; Meghan N Feldpausch; Amanda Martin; Kathy Melbourne; Virginia A Triant; Sujit Suchindran; Hang Lee; Udo Hoffmann; Kenneth C Williams; Ahmed Tawakol; Steven K Grinspoon Journal: JAMA Cardiol Date: 2016-07-01 Impact factor: 14.676
Authors: Ahmed Tawakol; Raymond Q Migrino; Gregory G Bashian; Shahinaz Bedri; David Vermylen; Ricardo C Cury; Denise Yates; Glenn M LaMuraglia; Karen Furie; Stuart Houser; Henry Gewirtz; James E Muller; Thomas J Brady; Alan J Fischman Journal: J Am Coll Cardiol Date: 2006-10-17 Impact factor: 24.094
Authors: Frank J Palella; Rebeccah McKibben; Wendy S Post; Xiuhong Li; Matthew Budoff; Lawrence Kingsley; Mallory D Witt; Lisa P Jacobson; Todd T Brown Journal: Open Forum Infect Dis Date: 2016-06-16 Impact factor: 3.835
Authors: Laura Jackisch; Warunee Kumsaiyai; Jonathan D Moore; Nasser Al-Daghri; Ioannis Kyrou; Thomas M Barber; Harpal Randeva; Sudhesh Kumar; Gyanendra Tripathi; Philip G McTernan Journal: Diabetologia Date: 2018-02-09 Impact factor: 10.122
Authors: Grace Shen; Teressa S Thomas; Allie R Walpert; Colin M McClure; Kathleen V Fitch; Christopher deFilippi; Martin Torriani; Colleen G Buckless; Gail K Adler; Steven K Grinspoon; Suman Srinivasa Journal: Clin Endocrinol (Oxf) Date: 2022-06-06 Impact factor: 3.523
Authors: Suman Srinivasa; Janet Lo; Milana Bogorodskaya; Kathleen V Fitch; Michael Lu; Martin Torriani; Markella V Zanni; Sara E Looby; Sanjna Iyengar; Virginia A Triant; Steven K Grinspoon Journal: Obesity (Silver Spring) Date: 2020-02-21 Impact factor: 5.002
Authors: Suman Srinivasa; Ruben Garcia-Martin; Martin Torriani; Kathleen V Fitch; Anna R Carlson; C Ronald Kahn; Steven K Grinspoon Journal: JCI Insight Date: 2021-09-22